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The herpes simplex virus type 1 UL12 gene product, alkaline nuclease (AN), appears to be involved in viral DNA processing
and capsid egress from the nucleus (Shao, L., Rapp, L. M., and Weller, S. K., Virology 196, 146–162, 1993). Although the HSV-1
AN is not absolutely essential for viral replication in tissue culture, conservation of the AN gene in all herpesviruses suggests
an important role in the life cycle of herpesviruses. The counterpart of HSV-1 AN for human cytomegalovirus (HCMV) is the
UL98 gene product. To examine whether the HCMV AN could substitute for HSV-1 AN, we performed trans-complementation
experiments using a HSV-1 amplicon plasmid carrying the HCMV UL98 gene. Our results indicate (i) HCMV AN can
complement the growth of the HSV-1 AN deletion mutant UL12lacZ virus in trans; (ii) a new recombinant virus, UL12laZcUL98/
99, appears to be generated by the integration of the HCMV UL98 gene into the HSV-1 UL12lacZ viral genome; (iii) in contrast
to its parental HSV-1 UL12lacZ virus, capsids formed in UL12lacZUL98/99-infected Vero cells were able to transport from the
nucleus to the cytoplasm and mature into infectious viruses. Our results demonstrate a functional conservation of AN
between HSV-1 and HCMV. © 1998 Academic Press
INTRODUCTION
During the late time of infection, herpes simplex virus
type 1 (HSV-1) DNA replicates via large concatemeric
intermediates, which are subsequently cleaved to gen-
erate unit-length genomes (Jacob et al., 1979; Vlazny and
Frankel, 1981; Mocarski and Roizman, 1982; Stow et al.,
1983). During or after cleavage of these concatemers, the
unit-length viral genome is packaged into capsids in the
infected cell nucleus, transported to the cytoplasm, and
subsequently released as enveloped viruses into the
extracellular space. Genetic studies clearly demonstrate
that the gene products of UL6, UL15, UL25, UL28, UL32,
and UL33 are required for viral DNA processing and
packaging. The involvement of the HSV-1 UL12 gene
product, alkaline nuclease (AN), has been implicated in
virion maturation, but its role in DNA processing is not
clear (Weller, et al., 1990; Shao et al., 1993).
HSV-1 AN is encoded by a 2.3-kb member of a family
of 39-coterminal mRNAs (Fig. 1; Costa et al., 1983; Draper
et al., 1986) and is a relatively abundant 85-kDa phos-
phoprotein in infected cells (Banks et al., 1983, 1985). The
enzymatic properties of HSV-1 AN as well as AN of the
Epstein–Barr virus have been characterized in vitro (Hoff-
mann and Cheng, 1978, 1979; Strobel-Fidler and Francke,
1980; Baylis et al., 1989; Bronstein and Weber, 1996).
Deletion mutant analysis of the HSV-1 UL12 gene
showed that (i) mutant viral yields were 0.1–1% of wild-
type (wt) levels and (ii) mutant viral DNA replication
appeared to be normal, but DNA-containing capsids
failed to egress from the nucleus to the cytoplasm of
infected cells (Weller et al., 1990; Shao et al., 1993).
Further study indicated that replicated mutant viral DNA
was not processed properly (Martinez et al., 1996a).
However, the exact role of the HSV-1 AN in the viral life
cycle remains to be determined. In addition, the UL12.5
gene product which is translated from a 1.9 mRNA is
39-coterminal with UL12 (Fig. 1) could not complement
the UL12 deletion, suggesting that the full-length HSV-1
AN must play an important role during replication in
tissue culture (Martinez et al., 1996b)
Although HSV-1 and human cytomegalovirus (HCMV)
differ remarkably in their biological characteristics and
the HSV-1 genome, with 153 kb, does not share signifi-
cant sequence homology with the 230-kb HCMV genome
(Huang and Pagano, 1974), both are members of the
family Herpesviridae and a number of genes, such as
genes involved in viral DNA replication, DNA cleavage,
and packaging, are conserved (Roizman, 1980). Based
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on gene arrangement and limited amino-acid sequence
homology, the HCMV UL98 gene was predicted to en-
code the homolog of HSV-1 AN. This prediction has been
confirmed recently by its activity in vitro (Sheaffer et al.,
1997). However, the biological role of the HCMV UL98
during the viral life cycle remains unknown.
The sequence arrangement of HSV-1 and HCMV ge-
nomes are very similar: both are composed of two
unique sequences, UL and US, each flanked by inverted
repeat regions such that the final structure can be rep-
resented as ab-UL-b9a9c9-US-ca. During the course of
viral infection, the two unique regions invert relative to
each other, generating four equimolar isomers of the
virus (Geelen and Westrate, 1982; reviewed by Roizman,
1979). Spaete and Mocarski (1984, 1985) reported that
the HCMV (strain Towne) L-S junction sequences could
replace an HSV-1 a sequence as a cis signal for cleav-
age and packaging into virions with an HSV-1 defective
virus amplicon construct. These results demonstrated
that the cis element for viral DNA cleavage and packag-
ing has been preserved over evolutionary time between
HSV-1 and HCMV, suggesting that other cis-and trans-
acting functions with the capability of cross complemen-
tation are likely to be present in the HSV-1 and HCMV
genomes.
In this manuscript, we report that the HCMV UL98
gene product, AN, can functionally substitute for HSV-1
AN and show that the defect of the HSV-1 AN deletion
mutant (UL12lacZ virus) is fully compensated by the
HCMV AN provided in trans.
RESULTS
Isolation and characterization of the AN mutant virus
Isolation and characterization of an HSV-1 KOS mutant
virus AN-1, which has a deletion spanning much of the
alkaline nuclease gene UL12, has been previously re-
ported (Weller et al., 1990; Shao et al., 1993; Martinez et
al., 1996a). To determine whether alkaline nuclease (AN)
is required for pathogenesis in a mouse model, we
constructed an AN mutant virus (UL12 lacZ) in the more
neurovirulent HSV-1 strain, 17 syn1 (Fig. 1). The mutant
virus UL12lacZ, contains a lacZ insertion in the UL12
gene and was detected as a blue plaque in the presence
of X-gal. Because there is a stop codon at the end of the
lacZ gene, only the N-terminal portion of AN was ex-
pected to be synthesized from the recombinant virus.
Thus the UL12lacZ virus encodes a fusion protein, with
the N-terminal 77 amino acids (aa) of AN fused to b-ga-
lactosidase, expressed under the control of the AN pro-
moter (Fig. 1).
To confirm the genetic structure of the recombinant
virus, the viral DNAs of HSV-1 wt (strain 17 syn1) and
UL12lacZ were digested with HindIII/BglII (Fig. 2A,
lanes 1 and 3) and BamHI/HindIII/EcoRI (lanes 2 and
4), then examined by Southern blot analysis. 32P-la-
beled pUL11/12 was used as a probe. Both wt and
UL12lacZ viral DNAs contained an identical HindIII/
BglII fragment (9.5 kb) (lanes 1 and 3). However, a
2.6-kb fragment observed in digested-wt DNA (lane 1)
was replaced by a 5.4-kb fragment in mutant DNA
(lane 3) due to the lacZ insertion. A 231-bp fragment
was not detected in either wt or mutant DNA because
they were run off the gel (lanes 1 and 3). When wt viral
DNA was digested with BamHI/HindIII/EcoRI, it gen-
erated a single 6.3-kb fragment (Fig. 2A, lane 2). In
contrast, this fragment was further digested into 4.7-
and 1.3-kb fragments in UL12lacZ viral DNA because of
the EcoRI site in the lacZ insertion (lane 4). We, there-
fore, concluded that the intended mutation was intro-
duced into the UL12lacZ viral DNA.
The viral mutant was next analyzed for expression of
FIG. 1. Map position of HSV-1 UL12 viruses. Nucleotide numbering of HSV-1 sequence accoding to McGeoch et al. (1988). Solid lines represent
HSV-1 DNA sequences and black bars represent coding sequences. The UL12 open reading frame starts at nt 27009 and terminates at nt 25008. The
mutant UL12lacZ virus encodes a fusion protein containing the N-terminal 77 aa of UL12 fused to b-galactosidase.
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AN-related polypetides. Vero cells were either mock-
infected or infected with virus, and cell extracts were
prepared at 10 h p.i. for Western blots (immunoblots).
Monoclonal antibodies (MAbs) specific for HSV AN (Fig.
3A) and b-galactosidase (Fig. 3B) were used, respec-
tively. An approximately 84-kDa protein, the expected
size of AN, was detected in the wt-infected cell extract
(Fig. 3A, lane 2). Another protein of approximately 60–65
kDa was also observed, which could be either a degra-
dation product of AN or the product of UL12.5 (Martinez
et al., 1996b). No AN-related proteins were detected in
the extracts of mock- or UL12lacZ-infected cells (Fig. 3A,
lanes 1 and 3). In contrast, when these proteins from
infected cell extracts were probed with a MAb specific
for b-galactosidase, the UL12lacZ fusion protein could
be detected in the mutant-infected cell extract (Fig. 3B,
lane 3) but not in mock- or wt virus-infected cell extracts
(Fig. 3B, lanes 5 and 4).
To further confirm that the UL12 gene of the UL12lacZ
virus was disrupted, the AN activity from virus-infected
cell extracts was measured. Significant nuclease activity
was observed in the wt-infected extract even at 5-min
incubation (Table 1). In contrast, the nuclease activity in
the UL12lacZ-infected cell extract was not above the
level of mock-infected cells following a 30-min incuba-
tion, indicating that the enzymatic activity of AN in
UL12lacZ virus was absent.
The growth properties of the UL12lacZ virus were very
similar to those of the HSV-1 AN-1 mutant (strain KOS) in
that they both exhibit (Weller et al., 1990; Shao et al.,
1993; Martinez et al., 1996a): (i) very small plaques in
Vero cells vs large plaques in permissive cell lines (6–5
or 3C5 cells); and (ii) the mutant virus yield in Vero cells,
determined by single-step growth analysis, was approx-
FIG. 2. (A) Southern analysis of HSV-1 wt and UL12lacZ DNAs. DNAs of wt (strain 17 syn1) and UL12lacZ viruses were digested with HindIII/BglII
(lanes 1 and 3) and BamHI/HindIII/EcoRI (lanes 2 and 4). Digested DNAs were separated on 0.8% agarose gels and transfered to nylon membranes.
32P-labeled pUL11/12 was used as a probe. (B) Southern analysis of viral DNA. Viral DNAs of HSV-1 wt-, HSV-1 UL12lacZ-, UL12lacZUL98/99–1-, and
UL12lacZUL98/99–2-infected Vero cells (lanes 1, 2, 4, and 5) and HSV-1 UL12lacZ-infected 3C5 cells (lane 3), were digested with BglII/NotI. 32P-labeled
HSV-1 pUL11/12 was used as a probe. (C) Same viral DNAs (lanes 1–5) were digested with the same enzymes as shown in (B). pHCMVUL98/99 [10
ng (lanes 6 and 13) and 1 ng (lanes 7 and 14)] was digested with the same enzymes. 32P-labeled pBR322 DNA was used as a probe for lanes 1–7.
After stripping the probe off, the same nylon membrane was rehybridized with 32P-labeled HCMV UL98/99 DNA (lanes 8–13). The locations of
molecular size markers are indicated.
FIG. 3. Western blot analysis of HSV-1 AN and HCMV AN in infected
cells. (A) Vero cells were infected with mock (lane 1), HSV-1 wt (lane 2),
or HSV-1 UL12lacZ (lane 3) and harvested at 10 h postinfection. Pro-
teins in the cellular extracts were separated by SDS–PAGE and trans-
ferred onto a nitrocellulose filter. The filter was then probed with MAb
to HSV AN (Q1). (B) Vero cells were infected with UL12lacZUL98/99–2
(lane 1), UL12lacZUL98/99–1 (lane 2), HSV-1 UL12lacZ (lane 3), HSV-1
wt (lane 4), or mock (lane 5), then processed as described in (A). The
filter was then probed with MAb to b-gal. The locations of molecular
size markers are shown at left.
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imately 100-fold less than wt virus (results not shown),
indicating that mutant virus growth was severely re-
stricted in Vero cells.
HCMV AN expressed from an HSV-1 amplicon can
functionally substitute for HSV-1 AN
Although the exact role of AN in the HSV-1 life cycle is
unclear, genetic analysis of HSV-1 AN mutants indicated
that AN is required for efficient processing of branched
viral DNA during replication (Shao et al., 1993; Martinez
et al., 1996a). Since the replacement of HSV-1 ‘‘a’’ se-
quence with the HCMV ‘‘a’’ sequence supported HSV-1
DNA replication with cleavage and packaging into HSV-1
capsids (Spaete and Mocarski, 1985), the cis or/and
trans elements required for “a” sequence functions must
be conserved between HSV-1 and HCMV. We, therefore,
examined whether the HCMV AN can functionally sub-
stitute for the HSV-1 AN.
Sequence comparison of AN among herpesvirus. De-
spite a low overall sequence homology (22% identity),
amino-acid-sequence alignment revealed the existence
of seven short colinear regions of sequence homology at
the C-terminal portions of HSV-1 AN and HCMV AN
(Martinez et al., 1996b). One dramatic difference between
the AN sequences is that the N-terminal 70 aa of HSV-1
AN is not shared by the AN of HCMV or other herpesvi-
ruses. The functional significance of these 70 aa for
HSV-1 AN is unknown.
Cellular distribution of AN of HSV-1 and HCMV. The
cellular distribution of HSV-1 and HCMV AN was exam-
ined prior to determining any functional conservation
between these two proteins. The HSV-1 AN has been
shown to localize to the nucleus in infected cells (Thom-
as et al., 1992). To determine whether HSV-1 AN or
HCMV AN can accumulate in the nucleus independent
of other viral proteins, the localization of both viral
ANs expressed in transfected cells was examined by
indirect immunofluorescence microscopy. As expected,
our results showed that both HSV-1 AN and HCMV AN,
expressed from plasmids, localized to the nucleus, indi-
cating that they contain the information necessary for
localization into the nucleus within their polypeptide se-
quence (Figs. 4A and 4F). In addition, the fusion protein,
consisting of the N-terminal 77 aa of HSV-1 AN fused to
b-gal, localized exclusively to the nucleus (results not
shown), suggesting that the first 77 aa of HSV-1 AN either
contains a nuclear localization signal (NLS) which could
direct the b-gal into the nucleus or this region interacts
with cellular proteins which can carry the fusion protein
into the nucleus. However, since there is no an apparent
NLS within the first 77 aa (except -PKRPRP- from resi-
dues 34–39), the mechanism by which these 77 aa direct
b-gal into the nucleus needs to be determined.
HCMV AN can functionally substitute for HSV-1 AN.
Trans-complementation experiments are usually used to
determine whether the growth defect of a HSV-1 mutant
virus can be compensated by a gene product provided in
trans. Complementation efficiency can also be enhanced
using an amplicon system (Berthomme et al., 1996).
However, because the HSV-1 AN is not absolutely re-
quired for viral growth in Vero cells (Weller et al., 1990),
there was a high background of mutant virus growth in
our initial trans-complementation experiments, making
our attempts to determine the ability of HCMV AN to
complement the growth of UL12lacZ virus inconclusive.
We therefore decided to use a HSV-1 amplicon system in
which plasmids carry the HSV-1 origin of replication and
packaging signals in addition to the desired gene (re-
viewed by Johnson and Friedmann, 1994). In the pres-
ence of helper virus (UL12lacZ), the amplicon DNA-ex-
pressing HCMV AN was amplified and packaged into
defective HSV-1 particles. If HCMV AN was able to func-
tionally substitute for HSV-1 AN, a coinfection with
UL12lacZ and the helper virus (packaged HCMV AN
amplicon), should have increased the burst size of
UL12lacZ. Ultimately, the yield of the UL12lacZ virus
would be much higher than background (minus ampli-
con) after a few rounds of passage on Vero cells.
Expression of our amplicon constructs were under the
control of the HCMV IE promoter (Hong et al., 1996). The
plasmid pHCMVUL98/99 encodes the HCMV AN and
UL99 gene products, while pHCMVUL98 only encodes
the HCMV AN (Fig. 5). We used the plasmid pHCM-
VUL98/99 for our initial studies. Vero cells were trans-
fected with amplicon plasmids encoding HCMV AN and
UL99 in either the correct or opposite orientation (Fig. 5,
pHCMVUL98/99 and pHCMVUL98/99R). At 16 h post-
transfection, cells were infected with UL12lacZ virus at
an m.o.i. of 0.2 for 40 h, with the resulting progeny virus,
designated passage zero, being titered on Vero cells and
HSV-1 AN-expressing 3C5 cells (Table 2). The virus pro-
duced in the cultures transfected with pHCMVUL98/99
showed a titer in 3C5 cells that was only fivefold higher
than virus produced in pHCMV/UL98/99R. However,
when these two virus stocks were used to infect Vero
cells, and their progeny viruses (passage 1) titered on
both cell types, we found a difference of more than 100
TABLE 1
Alkaline Nuclease Activity in wt or UL12lacZ
Virus-Infected Vero Cell Extracts
Infected with
Released 3H cpm at time of incubationa
09 59 309
Mock 944 924 1015
wt (strain 17) 1072 7230 13967
UL12lacZ 942 1010 1099
a The nuclease assay is described in the Materials and Methods.
Approximately 1.34 3 104 cpm would be released for each reaction if
digestion was complete.
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between the two viral titers in 3C5 cells. At passage 2, no
virus could be detected from cells transfected with pH-
CMVUL98/99R. These results suggest that HCMV AN
could complement the growth defect of UL12lacZ virus.
To ensure that enhancement of the growth of HSV-1
UL12lacZ virus was indeed due to the expression of
HCMV AN, an amplicon plasmid pHCMVUL98Kpn ex-
pressing a missense mutant HCMV AN was constructed.
This mutant AN with a 5-aa deletion at its C terminus
failed to complement the growth of HSV-1 UL12lacZ virus
(Fig. 5, results not shown). When these 5 aa were added
back to construct pHCMV UL98, the complementation by
HCMV AN expressed from the replicon plasmid was
restored (Fig. 5, results not shown).
The HSV-1 UL12lacZ virus formed very small plaques
on Vero cells, which can be readily distinguished from
large plaques of wt virus. A few large plaques were
observed in Vero cells at passage 1 of the UL98/99 stock
(Table 2). All large plaques were blue in the presence of
X-gal (results not shown), suggesting that (i) the lacZ
gene was still expressed from the UL12 lacZ virus and (ii)
formation of the large plaques is likely either due to the
spread of the UL12lacZ virus and defective amplicon
particles from co-infected single cells to adjacent cells or
the replication of a new recombinant virus in which the
HCMV UL98 gene is integrated into the UL12lacZ ge-
nome. To verify the genetic structure of these viral ge-
nomes, two large plaques, derived from two independent
transfections, were purified twice in Vero cells. Virus
stocks were made from these plaque-purified viruses,
FIG. 4. Cellular distribution of HSV-1 AN and HCMV AN. Vero cells were tranfected with pUL11/12 and the plasmid encoding ICP4 (A and D),
pUL12lacZ and the plasmid encoding ICP4 (B and E), and pHCMVUL98/99 (C and F). At 16 h posttransfection, cells were processed for indirect
immunofluorescence using MAbs specific for HSV AN (A–C) or HCMV AN (D–F). Vero cells were infected with HSV-1 wt (G), UL12lacZ (H) or
UL12lacZUL98/99 (I). AT 9 h postinfection, cells were processed for indirect immunofluorescence using a MAb specific for HCMV AN.
464 GAO ET AL.
designated UL12lacZUL98/99–1 and UL12lacZUL98/
99–2, for further analysis.
The HCMV AN gene integrated into the HSV-1 ge-
nome. Viral DNAs were isolated from wt-, UL12lacZ-,
UL12lacZUL98/99–1-, and UL12lacZUL98/99–2-infected
cells, digested with restriction enzymes, and analyzed by
Southern blots, using HSV-1 UL12 DNA (Fig. 2B), HCMV
UL98/99 DNA, and pBR322 DNA (Fig. 2C) as probes.
Digestion of total DNAs with BglII/NotI releases the
HCMV UL98/99 genes (Fig. 2C, lanes 13 and 14) from the
amplicon vector (Fig. 2C, lanes 6 and 7). When the HSV-1
UL12 gene was used as a probe, a 4.9-kb BglII/NotI
fragment was observed in all samples, while a 5.3-kb wt
DNA fragment was replaced by a 8.0-kb fragment in the
mutant DNA due to the lacZ gene insertion (compare Fig.
2B, lane 1 and lanes 2–5). This demonstrated that dis-
ruption of the HSV-1 UL12 gene by insertion of the lacZ
gene was not altered in the genomes of UL12lacZUL98/
99–1 and UL12lacZUL98/99–2 when compared to that of
the parental UL12lacZ virus. This was further confirmed
by the Western blot shown in Fig. 3B. The HSV-1
UL12lacZ fusion protein could be detected in UL12lacZ-,
UL12lacZUL98/99–1-, and UL12lacZUL98/99–2-infected
cell extracts (Fig. 3B, lanes 1–3). The same digested
DNAs were also hybridized with 32P-labeled vector
pBR322 DNA (Fig. 2C, lanes 1–5). The amplicon plasmid
pHCMVUL98/99 DNA digested with the same restriction
enzymes was used as a control, and a 6.8-kb vector DNA
fragment used in this experiment was detected (Fig. 2C,
lanes 6 and 7). However, a fragment with a size less than
the 6.8-kb vector DNA was observed in UL12lacZUL98/
99–1 DNA (Fig. 2C, lane 4), suggesting that the structure
of the vector DNA was altered. A more interesting finding
was that no vector DNA could be detected from the DNA
isolated from UL12lacZUL98/99–2-infected cells (Fig. 2C,
lane 5), indicating that the vector DNA was deleted out
from the amplicon. When the same blot was reprobed
with the HCMV UL98/99 DNA fragment, the HCMV
UL98/99 DNA sequence was detected (Fig. 2, lanes 11
and 12). In this case, restriction enzyme digestion pat-
FIG. 5. HSV-1 amplicons expressing HCMV UL98 related proteins. Arrows indicate the direction of HCMV UL88 and UL99 RNA transcripts.
Nucleotide numbering of HSV-1 sequence is according to Chee et al. (1990).
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terns of both viral DNAs were different from the insert of
the amplicon plasmid pHCMVUL98/99 (compare Fig. 2,
lanes 11 and 12 with lane 13).
We then examined the expression and cellular distri-
bution of HCMV AN in infected cells (Fig. 4). As expected,
the HCMV AN could be detected in the UL12lacZUL98/
99-infected cell nucleus (Fig. 4I) but not in the wt HSV-1-
or HSV-1 UL12lacZ-infected cells (Figs. 4G and 4H).
Taken together, these results clearly demonstrate that
the complementation of the growth of HSV-1 UL12lacZ
virus was due to the HCMV AN provided in trans.
The growth properties of these two viruses,
UL12lacZUL98/99–1 and UL12lacZUL98/99–2, were ex-
amined in Vero and 3C5 cells. Table 3 shows that titers
of both viruses in Vero cells and 3C5 cells were compa-
rable, but the sizes of plaques in UL12lacZUL98/99–1-
infected Vero cells were more heterogeneous, suggest-
ing that this viral stock contains either a mixture of the
UL12lacZ virus and defective amplicon particles or
UL12lacZ virus and UL12lacZUL98/99–1 virus. In con-
trast, no apparent size differences were noted for
UL12lacZUL98/99–2-infected Vero cells, suggesting that
the HCMV UL98 gene was integrated into the HSV-1
genome.
Electron microscopic study. It has been reported that
viral DNA was encapsidated in HSV-1 AN mutant-in-
fected Vero cells but was not transported from the nu-
cleus to the cytoplasm (Shao et al., 1993). Since HCMV
AN could complement the growth of the HSV-1 UL12lacZ
virus, the transport defect of mutant viral capsids was
examined in thin sections of UL12lacZUL98/99-infected
cells by electron microscopy (Fig. 6). In contrast to wt
HSV-1 (Fig. 6A), most of the capsids failed to transport
from the nucleus to the cytoplasm to form nature virions
in UL12lacZ-infected Vero cells, but viral DNA was still
encapsidated (Figs. 6B and 6D). Encapsidation of viral
DNA is confirmed at higher magnification (Fig. 6D). This
defect was compensated in UL12lacZ virus-infected 3C5
cells (Fig. 6E). HCMV AN could also complement the
defect of the UL12lacZ virus, because normal virions
were produced in UL12lacZUL98/99-infected Vero cells
(Fig. 6C).
DISCUSSION
UL12lacZ virus was constructed with two goals in
mind. One was to gain insight into the role of HSV-1 AN
in viral pathogenesis. Since HSV-1 strain 17 syn1 is more
neurovirulent than the strain KOS, we constructed
UL12lacZ virus in the background of strain 17. The ability
of this mutant and UL12lacZUL98/99 to replicate as well
as their neurovirulence has been examined in a mouse
model and will be discussed in a separate paper. The
second goal was to examine whether HCMV AN could
functionally substitute for HSV-1 AN because of the in-
volvement of HSV-1 AN in viral DNA processing and
capsid egress.
Some HSV-1 genes are not absolutely essential in
tissue culture, but they play important roles in viral patho-
genesis (Stow and Stow, 1986; Cai et al., 1992; Strelow
and Leib, 1995). However, it is difficult to dissect the
functional domains of these genes because mutant vi-
ruses bearing these mutations usually form small
plaques in noncomplementing cells, and consequently,
results obtained from the trans-complementaion experi-
ments are often inconclusive due to the high back-
ground. This obstacle sometimes can be overcome by
cotransfection of the mutant viral DNA with the desired
plasmid constructs (Cai and Schaffer, 1989). In this com-
munication, we describe another approach to study the
cross complementation between HSV-1 AN and HCMV
AN. This method is very sensitive because we took
advantage of the HSV-defective virus amplicon system
and showed, in Table 2, that the HSV-1 UL12lacZ virus
could not be detected after the first passage. There are
a few points to emphasize based on the results from
several independent experiments. First, transfection with
HCMV AN amplicon plasmids must be reasonably effi-
cient, otherwise, complementation indexes between the
wt and mutant plasmids would be similar, and a dramatic
TABLE 2
Ability of HCMV AN Amplicon to Complement
HSV-1 UL12lacZ Virusa
Amplicon
transfected
Passage
No. in Vero
cells
Virus titer (PFU/ml)b
3C5 cells Vero cells
pHCMVUL98/99 0 1.9 3 103 ,2 3 101
1 7.8 3 103 4 3 101
2 2.5 3 105 7.5 3 103
3 1.4 3 107 3.4 3 105
pHCMVUL98/99R 0 3.7 3 102 ,2 3 101
1 4.5 3 101 ,2 3 101
2 ,2 3 101 ,2 3 101
3 ND ND
a Vero cells were tranfected with the plasmids indicated. At 20 h
posttransfection the cells were infected with 0.2 PFU of HSV-1
UL12lacZ virus per cell and incubated for a further 48 h before being
harvested.
b Viral stocks were titered by plaque assay in the cell lines indicated.
ND, not determined.
TABLE 3
Growth of UL12lacZ/UL98-1 and UL12lacZ/UL98-2 Virusesa
Virus
Titer (PFU/ml)
3C5 Vero
UL12lacZ/UL98-1 2.8 3 107 1.1 3 107
UL12lacZ/UL98-2 3.6 3 107 3.2 3 107
a Viral stocks were titered by plaque assay in the cell lines indicated.
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difference would only be observed after several pas-
sages in Vero cells. Moreover, complementation by the
wt AN plasmid could be lost after the first passage if the
transfection efficiency was low, because the replication
and packaging of the amplicon are solely dependent on
the presence of HSV-1 UL12lacZ virus in the same cells.
Second, the m.o.i. used in these experiments was impor-
tant to make our results conclusive. Since lethal mutants
of HSV-1 are typically propagated in transformed com-
plementing cell lines, low levels of wt virus are often
present in the mutant virus stocks due to recombination
between homologous DNA sequences present in the
mutant virus genomes and in the chromosome of the
transformed cell line. Although the percentage of wt virus
in HSV-1 UL12lacZ virus stock was below our detection
limit (less than 0.1%), it was impossible for us to deter-
mine the exact number of wt virus in the mutant stock
because of the growth property of the mutant in non-
complementing cells. We, therefore, took the extra pre-
caution of using a very low m.o.i. for our cross-comple-
mentation experiments. In several independent experi-
ments, we never observed wt virus in the negative
controls, suggesting that no wt virus contamination ex-
isted in our HSV-1 UL12lacZ virus stock at the m.o.i. we
used.
Although it was clear from the data presented in this
report that the complementation of HSV-1 UL12lacZ
growth was due to the HCMV UL98 gene product, the
fact that plasmid DNA was not detected in DNA isolated
from UL12lacZUL98/99–2 virus-infected cells (Fig. 2C)
did not provide convincing evidence that the HCMV UL98
gene was integrated into the HSV-1 genome, because
the amplicon, like defective virus, could replicate and be
packaged in the presence of helper virus. However,
since the titer of UL12lacZUL98/99–2 virus and the size of
plaques were comparable in Vero and 3C5 cells, it was
FIG. 6. Electron micrographs of thin sections of HSV-1 wt-infected (A), UL12lacZ-infected (B, D, and E), or UL12lacZUL98/99-infected (C) Vero cells
(A–D) and 3C5 cells (E) at an m.o.i. of 5 PFU per cell. Cells were fixed and prepared at 16 h postinfection. Magnifications: 332,500 (A–C), 384,500
(D and E).
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strongly suggested that the HCMV UL98 gene was in-
deed integrated into the HSV-1 genome.
Although both the sequence homology and biological
characteristics of HSV-1 and HCMV have diverged sig-
nificantly, some cross-complementation has been ob-
served between HSV-1 and HCMV. Ng et al. (1996) re-
ported that the HCMV protein kinase UL97 could substi-
tute for the HSV-1 UL13 protein, allowing viral replication
in a cell line that restricts the growth of the UL13 deletion
mutant, although the functions of both proteins in the
viral life cycle remain to be determined. The ability of
trans-elements supplied by HSV-1 to cleave and package
an amplicon carrying the HCMV a sequence also dem-
onstrates some cis or/and trans functional conservations
between these two viruses (Spaete and Mocarski, 1984,
1985). From this point of view, the ability of HCMV AN to
complement the defect of HSV-1 UL12lacZ virus further
supports the observation that the HSV-1 AN might be
involved in viral DNA processing and the egress of cap-
sids. Currently, however, there is no direct evidence to
suggest that, in addition to HCMV AN, any individual
protein required for viral DNA cleavage/packaging can
be substituted between HSV-1 and HCMV. Based on the
phenotypic analysis of HSV-1 mutant viruses defective
for DNA cleavage/packaging, it is believed that these
two events are coupled. It is conceivable that a complex
consisting of multiple viral proteins are involved in DNA
cleavage/packaging and processing, so that homolo-
gous viral proteins fail to substitute for each other due to
abortive complex formation. If this is the case, it would
be most likely that HSV-1 AN plays a distinct role rather
than being a component of a complex involved in viral
DNA processing.
In this report, we provide a functional demonstration of
cross-complementation between HSV-1 AN and HCMV
AN. Since HSV-1 AN is absolutely essential for viral
replication in a mouse model (Gao et al., unpublished
observations), inhibitors of HSV-1 AN could serve as
antiviral drugs. The significance of these findings is that:
(i) it provides a tissue culture system to evaluate poten-
tial HCMV AN inhibitors determined in vitro, since the
requirement of AN in the HCMV life cycle is unknown,
and (ii) due to the cross-complementation, it provides
evidence that one single compound may inhibit both
viruses. Further analysis of HCMV AN, particularly in
term of its complementation ability for HSV-1 AN in an
animal model may aid in the discovery of a new class of
anti-HSV and anti-HCMV drugs.
MATERIALS AND METHODS
Cells and virus
Vero cells were grown and maintained as described
previously (Knipe et al., 1982). The growth medium for
UL12lacZ virus complementing-cell lines 6–5 (Weller et
al., 1990) and 3C5 (see below) included 250 mg of the
antibiotic G418 per milliliter.
The HSV-1 wt strain 17 syn1 was propagated and
assayed as described previously (Knipe et al., 1982). The
HSV-1 mutant UL12lacZ virus was isolated in 6–5 cells
and grown in 3C5 cells.
Plasmids
The plasmid pUL11/12 was constructed by cloning a
6.3-kb BamHI/HindIII fragment representing nt 21655–
27986 of HSV-1 strain 17 syn1 genome into pUC18
(Fig. 1). Plasmid pUL12lacZ was constructed as fol-
lows: after deletion of a 337-bp HpaI/XhoI fragment,
the lacZ gene (Shapira et al., 1983) was inserted.
Plasmids pHCMUL98/99 and pHCMUL98/99R were
constructed by the ligation of a 3.2-kb fragment rep-
resenting nt 142701–145998 of HCMV strain AD169
genome into pF9-CMV in both orientations (Hong et al.,
1996). Plasmid pHCMVUL98Kpn was constructed by
deletion of 1562-bp (nt 144436–145998 of the HCMV
genome) from the plasmid pHCMUL98/99. Thus
pHCMVUL98Kpn encodes the first 580 aa residues.
The oligonucleotide encoding the C-terminal 5 aa and
the stop codon were added back to pHCMVUL98Kpn
for generation of the plasmid pHCMVUL98.
Isolation of the HSV-1 AN-expressing cell lines and
HSV-1 UL12lacZ virus
Vero cells were transformed with the plasmid pUL11/12
and pSVneo as described previously (Gao and Knipe, 1989).
G418-resistant colonies were grown into cultures and
screened for the ability to complement the growth of
UL12lacZ virus. The cell clone 3C5 was used for experi-
ments in this study.
The plasmid pUL12lacZ was transfected with infec-
tious HSV-1 strain 17 syn1 DNA into 6–5 cells with the
recombinant viruses identified as blue plaques.
Analysis of viral DNA and proteins
Viral DNAs for Southern blotting were prepared as
described previously (Gao and Knipe, 1989). For Western
blot analysis, infected cell lysates were analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS–PAGE) (Gao and Knipe, 1989). The procedure
for Western blot analysis was described previously (Gao
and Knipe, 1989). The anti-HSV-2 monoclonal antibody
(MAb) Q1 (Banks et al., 1983) was used to detect HSV-1
AN. A MAb against b-gal was used to detect expression
of b-galactosidase from mutant viruses UL12lacZUL98/
99–2-, UL12lacZUL98/99–1-, and UL12lacZ- infected cells
(Fig. 3, lanes 1–3).
Alkaline nuclease assay
Preparation of HSV-infected cell extracts and the nu-
clease assays were performed essentially as described
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by Weller et al. (1990). The assay mixture (100 ml) con-
tained the following components: 50 mM Tris-HCl (pH
9.0), 2 mM MgCl2, 10 mM 2-mercaptoethanol, 10 mg un-
labelled salmon sperm DNA, 35S-labeled salmon sperm
DNA (6 3 104 cpm per reaction), and 1 ml of crude cell
extracts. Reactions were carried out at 37°C and 30-ml
aliquots were withdrawn at 0, 5, and 30 min. Degradation
of the labeled DNA was monitored by release of acid-
soluble 35S-labeled nucleotides in the supernatant after
precipitation with 6% Trichloroacetic acid.
Electron microscopy
The procedure for examination of infected cells by
electron microscopy was described previously (Gao et
al., 1994).
Trans complementation assays
The procedure for trans complementation has been
described previously (Gao et al., 1994). Vero cells were
transfected with 2.5 mg of plasmid DNA into Vero cells in
24-well plates. At 16–20 h posttranfection, the cells were
infected with 0.2 PFU HSV-1 UL12lacZ virus per cell.
Virus yield was measured by plaque assay on 3C5 and
Vero cells.
Indirect immunofluorescence
Indirect immunofluorescence was performed as de-
scribed previously (Gao et al., 1994). Monoclonal anti-
body (MAb) Q1 (Banks et al., 1983) for detection of HSV-1
AN (1:100 dilution) was a gift from K. Powell (Strategic
Medical Research, London, England. MAb I2 (Adam et
al., 1995) for detection of HCMV AN (1:100 dilution) was
a gift from J. Nelson (Oregon Health Sciences University).
A fluorescein-conjugated goat anti-mouse antibody was
used as the secondary antibody (1:100 dilution).
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